FOR M&A LAW FIRMS

Complete Diligence in Days, Not Weeks

Whether you're on the buy or sell side, Marveri gives you a full picture on day one of data room access. Every result verifiable.

Book a Demo

Organize any data room

Any set of files, organized into your standard naming conventions and folder structure. Easily review even the messiest of data rooms. On the sell side, give your clients a polished data room ready to impress the buyers.

AMENDED AND RESTATED CERTIFICATE OF INCORPORATION (1).pdf
Organizational Documents
8
Audited Financials 2023 2024 FINAL.pdf
Formation Documents
3
employment agreement - morrison (executed copy).pdf
Certus, Inc. - Amended and Restated Certificate of Incorporation - August 30, 2023.pdf
Lease Agreement 200 Congress Austin TX.pdf
Certus, Inc. - Amended and Restated Bylaws - March 15, 2024.pdf
CUSTOMER_LIST_CONFIDENTIAL.xlsx
Certus, Inc. - Certificate of Good Standing (Delaware) - January 10, 2026.pdf
Meridian_Health_MSA_2022_executed (signed by both parties).pdf
Board and Stockholder Consents
5
D&O policy renewal cert 2024.pdf
Material Contracts
12
Board consent re option grants 9-15-23.pdf
Certus, Inc. - Master Services Agreement (Meridian Health Systems) - June 15, 2022.pdf
IP Assignment - Chen.pdf
Certus, Inc. - Distribution Agreement (Whitfield & Partners LLP) - August 15, 2023.pdf
Non-Compete (Morrison) final executed.pdf
Employment
11
Wells Fargo Credit Agreement (revolving).pdf
Executive Employment Agreements
4
federal and state tax returns.zip
Certus, Inc. - Employment Agreement (James Morrison, CEO) - March 1, 2021.pdf
Stock Option Plan 2020 as amended.pdf
Certus, Inc. - Non-Competition Agreement (James Morrison) - March 1, 2021.pdf
DISTRIBUTOR AGREEMENT (signed).pdf
Financial Statements
6
Environmental Phase I - 200 Congress Ave (2019).pdf
Certus, Inc. - Audited Financial Statements (FY2024) - March 28, 2025.pdf
pending_litigation_summary.pdf
Insurance
6
Workers Comp Insurance Certificate.pdf
Certus, Inc. - Directors and Officers Liability Policy - February 1, 2024.pdf
Certus, Inc. — Due Diligence Request List.xlsx
DUE DILIGENCE REQUEST LIST
Date: April 2, 2026 · Project Redwood · Generated by Marveri
ID
Category
Request
Response
Status
Responsive Docs
Internal Notes
10
A.7
Officers & Directors
List of current officers, directors, and key employees.
• J. Chen (CEO, Director)
• S. Connolly (President, Secretary)
• D. Mishkin (CFO, Treasurer)
• M. Torres (Independent Director)
Provided
Board Consent (appt).pdf ↗
Indemnification Agmts.zip ↗
Org Chart (2026).pdf ↗
Torres appointed per Series B term sheet. Board observer: Redpoint per IRA §3.1.
11
A.8
Subsidiaries
List of all subsidiaries, joint ventures, and foreign qualifications.
Certus UK Ltd. (wholly owned). Certus Solutions LLC (wholly owned). No joint ventures. Foreign qualified in CA, NY, TX.
Provided
UK Certificate of Inc.pdf ↗
LLC Op. Agreement.pdf ↗
Foreign Qual. Certs.zip ↗
UK sub formed for EU customer contracts. TX qualification lapsed Dec 2025 — reinstatement pending.
12
B
Capitalization and Securities Matters
13
B.1
Capitalization
Fully-diluted cap table including options, warrants, convertibles, SAFEs.
See attached. Common: 28.4M shares. Preferred: Series A (4.2M), A-1 (2.1M), B (8.6M). Options: 3.8M. Warrants: 1.2M.
In Progress
Cap Table (Mar 2026).xlsx ↗
Warrant Ledger.xlsx ↗
Warrant Calculation DiscrepancyWarrant ledger shows 1.2M; Series B SPA side letter references 1.45M. 250K shares unreconciled.
14
B.2
Equity Documents
All agreements relating to issuances of equity, options, and warrants.
See documents in folder B.2.
Provided
SPA (Series B).pdf ↗
SPA (Series A).pdf ↗
RSPA (Connolly).pdf ↗
RSPA (Mishkin).pdf ↗
+ 62 more
409A Valuation StaleMost recent 409A dated Sept 2024 (18 mos). Post-Jan 2025 grants lack safe harbor.
15
B.3
SAFEs & Notes
SAFEs, convertible notes, and all convertible instruments.
See responsive documents in folder B.3.
In Progress
SAFE (YC).pdf ↗
SAFE (Angel Synd.).pdf ↗
Conv. Note (2020).pdf ↗
+ 2 more
MFN Clause Triggered2018 SAFE ($6M cap) includes MFN. Subsequent SAFE at $4.5M cap — earlier holders may claim lower cap.
16
B.4
Equity Incentives
Equity incentive plans and all option/RSU grant agreements.
See documents in folder B.4.
Provided
2019 Equity Plan.pdf ↗
Grant Agreements.zip ↗
Board Consent (Plan).pdf ↗
+ 44 more
Single-Trigger Acceleration8 executive grants include single-trigger acceleration on CoC. Aggregate: 1.4M shares.
20
C
Material Contracts

Respond to any diligence request list

Upload any diligence request list. On the sell side, Marveri responds to every request based on every data room document. Ready to review and send to the buyer on day one. On the buy side, see how the seller should be responding to your requests based on the entire data room they've provided.

Detect what’s missing. Know exactly what to ask for.

Marveri flags gaps across the entire document set (missing board approvals, amendments, employment documentation, signatures, and more) and produces a verifiable supplemental request list. On the buy side, send it to the target on day one. On the sell side, identify gaps before the buyer does.

Missing Documents
Commercial and IP Agreements 13 Documents
×
1 / 12 Page Width +

Surface any clause across every document

Change-of-control, assignability, exclusivity, uncapped liability, consent requirements, or anything else, instantly identified across the entire data room. Every result explained and cited to the source document.

A Complete Diligence Report, From Every Document in the Data Room

Upload your data room and Marveri reviews, cross-references, and analyzes every document, producing a comprehensive, fully cited diligence report.

Corporate governance

Company history, board structure, requisite approvals.

Capitalization

Cap table tie-out, board authorization, vesting, cross-document consistency.

Employment

Compensation, restrictive covenants, key employee census.

Material contracts

Commercial posture, concentration risk, license review.

Intellectual property

Ownership chain, assignment gaps, IP asset inventory.

Litigation & disputes

Pending and threatened matters across the full document set.

See how cap table tie-outs work →
Due Diligence Report
Synthetica AI, Inc. — Project Alpine
Prepared by Marveri
Date March 28, 2026
Executive Summary

Synthetica AI, Inc. is a Delaware corporation operating a cloud-hosted enterprise AI platform [9], currently party to a merger agreement with Apex Software Corporation [10] (closing targeted by June 30, 2026). This report reviews corporate formation and governance documents [25], capitalization records [27], financing documents [26], material contracts, intellectual property filings [21], litigation records [20], insurance policies [1], [2], [3], employment records [28], tax filings [33], and audited financial statements [6].

The following findings define the company’s current legal posture:

  • Unresolvable capitalization uncertainty. Series A preferred shares appear as 0 [6], 4.5 million [8], or 15 million [7] outstanding across four sources, directly affecting every approval threshold for the merger.
  • Critical documentation gaps. Bylaws, all Stock Purchase Agreements, the equity incentive plan, the stock ledger, the credit agreement, and stockholder consents for the February 2025 Series C financing [26] are among dozens of material documents not produced.
  • Expired and at-risk contracts. The AWS enterprise agreement [17] expired December 2025. The JPMorgan Chase technology MSA [13] expired approximately February 2026. Three insurance policies expired February 15, 2026 with no evidence of renewal.
  • Change-of-control consents. Four agreements require consent or notice for the merger [7]; none has been obtained [10].
  • IP ownership gaps and active patent litigation. Two patents were filed before or days after incorporation without documented assignment [21], and NeuralPath Technologies has filed a patent suit in D. Del. [20] asserting a patent bearing the same number the company claims as its own.
  • R&D tax credit discrepancies. The $4.8M credit on the filed return [33] is nearly double the $2.5M produced by the supporting Deloitte study [34].
Company Timeline

The following table reconstructs key corporate, financing, and operational events. Events in bold present open diligence issues.

DateEventSource
Jan. 15, 2020Incorporation (Delaware); Certificate of Incorporation filed[25]
Jan. 2020Marchetti employment agreement references option grant — no 409A valuation exists[23]
Mar. 15, 20202020 Equity Incentive Plan adopted (not produced)[27]
Feb. 15, 2021Stanford exclusive license executed (10-year term)[19]
Nov. 2021Series A financing — 15M shares at $1.60/share ($24M); Sequoia Capital lead[7]
Mar. 31, 2022First documented 409A valuation — $0.52/share[27]
Mar. 1, 2023JPMorgan Chase Technology MSA executed ($2.4M/yr)[13]
Jun. 2023Series B financing — 10M shares at $5.50/share ($55M); a16z lead[7]
Jan. 1, 2023AWS Enterprise Agreement executed ($3.6M committed)[17]
Dec. 31, 2025AWS Enterprise Agreement expired — no renewal documented[17]
Feb. 2025Series C financing — 7.5M shares at $12.00/share ($90M); Tiger Global lead[7]
Feb. 15, 2026D&O, CGL, and Cyber insurance policies all expired[1][2][3]
Feb. 15, 2026Board unanimously approves merger agreement with Apex Software Corp.[10]
Feb. 28, 2026JPMorgan Chase MSA expired — no renewal documented[13]
Jun. 30, 2026Merger closing deadline (reverse triangular; Synthetica survives as Apex subsidiary)[10]

Dates reconstructed from [6], [7], [8], [10], [13], [17], [19], [23], [25], [27]

Corporate Structure and Governance
Entity Status and Organizational Documents

Good standing. A Good Standing Certificate dated January 31, 2026 confirms good standing in Delaware with all franchise taxes current. [35] The company is qualified as a foreign corporation in California, New York, Texas, Washington, Massachusetts, Colorado, and Illinois. [7]

Delaware file number discrepancy. The Good Standing Certificate references File No. 4524987 [35], while the Disclosure Schedules and CEO Certificate both reference File No. 5412891. [7], [8]

Probable UK subsidiary. The audited financials are styled as “Consolidated” and disclose a London lease [6]. No subsidiary formation documents, intercompany agreements, or entity details appear in the reviewed documents.

Charter Provisions
Class / SeriesAuthorizedPar ValueIssuance PriceAnti-Dilution
Common Stock140,000,000$0.0001
Series A Preferred15,000,000$0.0001$1.60Broad-based WA
Series B Preferred10,000,000$0.0001$5.50WA + Full Ratchet
Series C Preferred7,500,000$0.0001$12.00Broad-based WA
Undesignated Preferred27,500,000$0.0001
Total200,000,000

Source: [25 (A&R Certificate of Incorporation)]

Anti-dilution conflict. The charter [25] provides broad-based weighted average anti-dilution for Series A and B, but Series B additionally carries full ratchet protection for down-rounds below $5.50/share. The IRA [26] describes only broad-based weighted average for all series. Under Delaware law, the charter controls.

Capitalization
RoundDateShares IssuedPrice/ShareGross ProceedsLead Investor
Series ANov. 202115,000,000$1.60$24,000,000Sequoia Capital
Series BJun. 202310,000,000$5.50$55,000,000Andreessen Horowitz
Series CFeb. 20257,500,000$12.00$90,000,000Tiger Global
Total Preferred Raised$169,000,000

Sources: [7], [27], [6]

Preferred Stock: material inconsistency. Three mutually inconsistent positions exist. The equity statement [6] shows zero preferred shares at the January 1, 2024 opening balance. Yet the funding history in the Disclosure Schedules [7] confirms 15,000,000 Series A shares were issued in November 2021.

SourceSeries ASeries BSeries CTotal PreferredMajority Threshold
Audited Financials [6]010,000,0007,500,00017,500,0008,750,001
CEO Certificate [8]4,500,00010,000,0007,500,00022,000,00011,000,001
Disc. Sched. / Cap Table [7], [27]15,000,00010,000,0007,500,00032,500,00016,250,001

Discrepant figures shown in bold. Majority threshold per Section 4.5 of [25].

Material Contracts
CounterpartyTypeAnnual ValueTermCoC ConsentStatus
JPMorgan ChaseTechnology MSA$2,400,0003/1/23–2/28/26YesExpired
Amazon Web ServicesEnterprise EA$1,200,0001/1/23–12/31/25YesExpired
Stanford UniversityExclusive License~$768,0002/15/21–2/15/31YesActive
Silicon Valley BankCredit Facility$20,000,000Not producedYesUnknown
Tishman SpeyerOffice Lease (SF HQ)$1,080,0003/1/22–2/28/27YesActive
Deloitte & ToucheAudit Engagement$385,000Annual renewalNoActive
SalesforceCRM Subscription$192,0007/1/24–6/30/27NoActive

Sources: [13], [17], [19], [7], [30], [6], [11], [12], [14]

Insurance covenant noncompliance. The JPMorgan MSA [13] requires $10M cyber liability, $5M CGL per occurrence, $5M E&O, and $5M D&O. Current cyber coverage is $5M [3] and CGL is $1M per occurrence / $2M aggregate [2], both below contractual requirements.

Credit agreement not produced. The Disclosure Schedules [7] reference a $20M revolving credit facility with Silicon Valley Bank. The credit agreement itself, any amendments, compliance certificates, and current draw amounts were not included in the data room [30].

A complete disclosure schedule — drafted from every rep in the purchase agreement

Marveri reads every representation and warranty in your purchase agreement, with all their qualifiers and carve-outs, and cross-references every document in the data room to draft the full schedules. Every disclosure is cited to its source, ready for your team to finalize.

1

Upload

Upload the purchase agreement and data room

2

Analyze

Marveri maps every rep to responsive documents and drafts the schedules

3

Export

Export first draft to Word, every disclosure cited to source documents

Learn more about disclosure schedules →
Schedule 3.7
Material Contracts
(a) Contracts Requiring Consent to Assignment or Containing Change-of-Control Provisions.
1. Master Services Agreement, dated January 15, 2022, between Meridian Health Systems, Inc. and the Company (consent to assign; CoC termination right). [7.01]
2. Enterprise License Agreement, dated September 1, 2023, between Apex Financial Corp. and the Company (automatic termination upon CoC). [7.04]
3. Data Processing Agreement, dated March 22, 2023, between NovaTech Solutions GmbH and the Company (consent to assign, not to be unreasonably withheld). [7.09]
[Internal Note: The Apex ELA (item 2) provides for automatic termination upon change of control with no cure period. Buyer counsel should obtain waiver prior to closing.]
(b) Contracts Involving Annual Payments in Excess of $250,000.
1. The contracts listed in Section (a)(1) through (a)(3) above.
2. SaaS Subscription Agreement, dated June 1, 2022, between Caldwell Group, LLC and the Company. [7.12]
3. Platform License Agreement, dated February 28, 2024, between Commonwealth Bancshares and the Company. [7.18]
4. Reseller Agreement, dated August 15, 2023, between Whitfield & Partners LLP and the Company. [7.22]
(c) Non-Competition and Non-Solicitation Agreements.
1. Non-Competition Agreement, dated March 1, 2021, between the Company and David R. Harmon (CEO). [7.30]
2. Restrictive Covenant Agreement, dated June 15, 2022, between the Company and Sarah K. Whitmore (CTO). [7.31]
3. Non-Solicitation Agreement, dated January 10, 2023, between the Company and James L. Osbourne (VP, Sales). [7.32]
[Internal Note: Enforceability of the Harmon non-compete (24 months) under Cal. Bus. & Prof. Code § 16600 should be evaluated by Buyer.]
(d) Guarantees and Letters of Credit.
1. Irrevocable Standby Letter of Credit No. LC-2023-0491, issued by Silicon Valley Bank, N.A., dated April 5, 2023 ($500,000). [7.40]
2. Personal Guaranty, dated March 1, 2021, by David R. Harmon in favor of First Republic Bank, N.A., re: Revolving Credit Facility ($3,000,000). [7.41]

Even more tools M&A lawyers love

Redline and compare at scale

Compare 2 documents or 20, all at once. The most advanced comparison tool in the industry.

Ask any question. Get a cited report.

Run any query across your data room. “Which contracts have uncapped indemnity obligations?” Every result comes with verifiable citations.

Automatic OCRDocument summariesDuplicate detectionMissing signature detectionSupport for 100+ languagesRole-based access controlExportable clause tablesOne-click index downloadCross-document referencesCustom extraction columnsChange of control provisionsAnti-assignment analysisIP license reviewTermination provision searchNon-compete analysisGoverning law extractionExport to Word with citationsExport to Excel with citationsCompany overview reportPersonnel & compensation censusCorporate structure mappingExact quote verificationVerified math calculationsMulti-worksheet analysisDocument status trackingName history trackingConcurrent research threadsDownload reports as WordGoogle Drive integrationSharePoint / OneDrive syncLocal folder syncSOC 2 Type II certified
SOC 2 Type II compliance badge

Security Designed for the Most Confidential Data

Encryption of all data in transit and at rest.
SOC 2 Type II.
Zero training.

What our Customers are Saying:

"I remain blown away by the product."
- Corporate Partner
“Marveri is the single greatest product I’ve ever used.”
- Founding Corporate Partner
"Dream come true."
- Junior Associate
"I’m sold. Going to start requiring anyone working on my clients to use Marveri."
- Founding Senior Attorney
"I literally love Marveri and can’t imagine not having it."
- Junior Associate
"I remain blown away by the product."
- Corporate Partner
“Marveri is the single greatest product I’ve ever used.”
- Founding Corporate Partner
"Dream come true."
- Junior Associate
"I’m sold. Going to start requiring anyone working on my clients to use Marveri."
- Founding Senior Attorney
"I literally love Marveri and can’t imagine not having it."
- Junior Associate
“Your product is criminally cheap.”
- Head of Small Law Firm
“Finally found the perfect tool.”
- Senior M&A attorney
“I’m only a week in and already getting 10x the value.”
- Senior Fund Lawyer
"Your product is amazing."
- Corporate Partner
“Your product is criminally cheap.”
- Head of Small Law Firm
“Finally found the perfect tool.”
- Senior M&A attorney
“I’m only a week in and already getting 10x the value.”
- Senior Fund Lawyer
"Your product is amazing."
- Corporate Partner
Close

See for yourself.

Close

Success

Your submission has been received.
Oops! Something went wrong while submitting the form.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.